Publication & Citation Trends
Most Cited Works
Publications
23 total
Is "Do Everything!" Always Appropriate?
Cited by 0
Semantic Scholar
Abstract P3-12-01: Impact of treatment on quality of life (QOL) and menstrual history (MH) in the NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide
Cited by 2
Semantic Scholar
Phase I dose finding study of carboplatin, paclitaxel, and temozolomide in advanced solid tumors
Cited by 0
Semantic Scholar
Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer
Cited by 159
OpenAlex
Participation among breast cancer patients in a prospective cancer registry and quality of specimens collected for a tissue repository: the Expanded Breast Cancer Registry and Tissue Repository (EBCR) experience.
Cited by 0
Semantic Scholar
Molecular marker correlates of clinical outcome in a phase II study of gefitinib or placebo in combination with anastrozole in postmenopausal women with hormone receptor-positive metastatic breast cancer.
Cited by 4
Semantic Scholar
Adjuvant Therapy with Curative Intent: Is That Really So?
Cited by 0
Semantic Scholar
Research Topics
Cancer Treatment and Pharmacology
(7)
HER2/EGFR in Cancer Research
(5)
Advanced Breast Cancer Therapies
(4)
Lymphoma Diagnosis and Treatment
(2)
Hematopoietic Stem Cell Transplantation
(2)
Frequent Co-Authors
Affiliations
The University of Texas MD Anderson Cancer Center
Cairo University
Oregon Health & Science University
University of New Mexico
University of Colorado Boulder